(Q57515350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

editorial

0 references

title

Funding of drugs: do vaccines warrant a different approach? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

C Raina MacIntyre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Philippe Beutels

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

727-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18992409%20AND%20SRC:MED&resulttype=core&format=json

Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future

26 December 2019

cites work

1 reference

12 December 2020

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

12 December 2020

Eradication versus control for poliomyelitis: an economic analysis.

1 reference

12 December 2020

World wide experience with inactivated poliovirus vaccine

1 reference

12 December 2020

Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season

1 reference

12 December 2020

Herd immunity: history, theory, practice

1 reference

12 December 2020

School-based influenza vaccination program reduces influenza-related outcomes among household members

1 reference

12 December 2020

Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policy

1 reference

12 December 2020

Is G8 putting profits before the world's poorest children?

1 reference

12 December 2020

Economic Evaluation of Vaccination

1 reference

12 December 2020

The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK.

1 reference

12 December 2020

Measles vaccination improves the equity of health outcomes: evidence from Bangladesh

1 reference

12 December 2020

Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion

1 reference

12 December 2020

Saving future lives. A comparison of three discounting models

1 reference

12 December 2020

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

1 reference

12 December 2020

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.

1 reference

12 December 2020

Improving uptake of MMR vaccine

1 reference

12 December 2020

Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial.

1 reference

12 December 2020

Cost-effectiveness of a routine varicella vaccination program for US children

1 reference

12 December 2020

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium

1 reference

12 December 2020

The Global Burden of Disease assessments--WHO is responsible?

1 reference

12 December 2020

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

1 reference

12 December 2020

PHARMAC responds to Richard Milne on discounting health benefits and costs

1 reference

12 December 2020

Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.

1 reference

12 December 2020

Impact of anti-vaccine movements on pertussis control: the untold story

1 reference

12 December 2020

The cost-effectiveness of rotavirus vaccination in Australia

1 reference

12 December 2020

Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty

1 reference

12 December 2020

Estimating the number of deaths with rotavirus as a cause in England and wales

1 reference

12 December 2020

Varicella vaccination in England and Wales: cost-utility analysis

1 reference

12 December 2020

An economic evaluation of varicella vaccination in Italian adolescents

1 reference

12 December 2020

Comments on the Prosser et al Approach to Value Disease Reduction in Children

1 reference

12 December 2020

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

12 December 2020

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

Need for differential discounting of costs and health effects in cost effectiveness analyses

1 reference

12 December 2020

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health

1 reference

12 December 2020

Methodological issues and new developments in the economic evaluation of vaccines

1 reference

12 December 2020

Cost-effectiveness and potential impact of rotavirus vaccination in the United States

1 reference

12 December 2020

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine

1 reference

12 December 2020

The economic impact of SARS: how does the reality match the predictions?

1 reference

12 December 2020

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States

1 reference

12 December 2020

Epidemiology of rubella and congenital rubella syndrome in Greece, 1994-2003.

1 reference

12 December 2020

Cost-effectiveness analyses of human papillomavirus vaccination

1 reference

12 December 2020

Human Papillomavirus Vaccination — Reasons for Caution

1 reference

12 December 2020

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia

1 reference

12 December 2020

Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia

1 reference

12 December 2020

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

12 December 2020

Time preference, the discounted utility model and health

1 reference

12 December 2020

Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.

1 reference

12 December 2020

Tiered pricing of vaccines: a win-win-win situation, not a subsidy.

1 reference

12 December 2020

Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases

1 reference

12 December 2020

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

1 reference

12 December 2020

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

1 reference

12 December 2020

Vaccine adverse events: separating myth from reality

1 reference

12 December 2020

Precautionary behavior in response to perceived threat of pandemic influenza.

1 reference

12 December 2020

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

1 reference

12 December 2020

Economic evaluations of varicella vaccination programmes: a review of the literature

1 reference

12 December 2020

Chapter 33 Economic epidemiology and infectious diseases

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970258-5

7 January 2021

inferred from DOI database lookup

The Social Rate of Discount and The Optimal Rate of Investment

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970258-5

7 January 2021

inferred from DOI database lookup

Epidemiology of rubella and congenital rubella syndrome in Greece, 1994-2003.

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970258-5

7 January 2021